KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for CRISPR Therapeutics AG (CRSP) over the last 11 years, with Q4 2025 value amounting to -$787000.0.

  • CRISPR Therapeutics AG's Other Working Capital Changes fell 34715.91% to -$787000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.3 million, marking a year-over-year increase of 3685.9%. This contributed to the annual value of -$3.3 million for FY2025, which is 3685.9% up from last year.
  • As of Q4 2025, CRISPR Therapeutics AG's Other Working Capital Changes stood at -$787000.0, which was down 34715.91% from -$834000.0 recorded in Q3 2025.
  • In the past 5 years, CRISPR Therapeutics AG's Other Working Capital Changes registered a high of $9.3 million during Q3 2021, and its lowest value of -$12.0 million during Q1 2023.
  • In the last 5 years, CRISPR Therapeutics AG's Other Working Capital Changes had a median value of -$829000.0 in 2025 and averaged -$976350.0.
  • In the last 5 years, CRISPR Therapeutics AG's Other Working Capital Changes surged by 21235.86% in 2022 and then tumbled by 54361.7% in 2025.
  • Quarter analysis of 5 years shows CRISPR Therapeutics AG's Other Working Capital Changes stood at -$4.9 million in 2021, then skyrocketed by 212.36% to $5.5 million in 2022, then crashed by 218.05% to -$6.4 million in 2023, then soared by 97.27% to -$176000.0 in 2024, then tumbled by 347.16% to -$787000.0 in 2025.
  • Its Other Working Capital Changes was -$787000.0 in Q4 2025, compared to -$834000.0 in Q3 2025 and -$892000.0 in Q2 2025.